Oxaliplatin/fluorouracil ‐based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta‐analysis of randomized controlled trials

ConclusionAdjuvant Oxaliplatin/fluorouracil‐based chemotherapy can improve DFS of patients after NCRT and radical surgery, compared with adjuvant fluorouracil‐based chemotherapy. Data of the longer‐term survival outcome are needed.This article is protected by copyright. All rights reserved.
Source: Colorectal Disease - Category: Gastroenterology Authors: Tags: Systematic Review Source Type: research